{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:05:23Z","timestamp":1793289923220,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["601852"],"award-info":[{"award-number":["601852"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003123","name":"Fetal Medicine Foundation","doi-asserted-by":"publisher","award":["1037116"],"award-info":[{"award-number":["1037116"]}],"id":[{"id":"10.13039\/501100003123","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Quebec Health Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ajog.2025.10.032","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T17:00:28Z","timestamp":1761930028000},"page":"770-778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The effect of aspirin on the risk of preeclampsia based on the Fetal Medicine Foundation first-trimester risk"],"prefix":"10.1016","volume":"234","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6936-4369","authenticated-orcid":false,"given":"Emmanuel","family":"Bujold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.","family":"Rolnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liona","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argyro","family":"Syngelaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kypros H.","family":"Nicolaides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2025.10.032_bib1","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMra2109523","article-title":"Preeclampsia","volume":"386","author":"Magee","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2025.10.032_bib2","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1515\/cclm.2011.764","article-title":"Linking preeclampsia and cardiovascular disease later in life","volume":"50","author":"Gigu\u00e8re","year":"2012","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ajog.2025.10.032_bib3","doi-asserted-by":"crossref","first-page":"S895","DOI":"10.1016\/j.ajog.2020.09.026","article-title":"Failure of physiological transformation and spiral artery atherosis: their roles in preeclampsia","volume":"226","author":"Staff","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.032_bib4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajog.2010.08.009","article-title":"The \u201dGreat Obstetrical Syndromes\u201d are associated with disorders of deep placentation","volume":"204","author":"Brosens","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.032_bib5","doi-asserted-by":"crossref","first-page":"S1071","DOI":"10.1016\/j.ajog.2020.07.020","article-title":"First trimester preeclampsia screening and prediction","volume":"226","author":"Chaemsaithong","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.032_bib6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ajog.2019.11.1247","article-title":"The competing risk approach for prediction of preeclampsia","volume":"223","author":"Wright","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.032_bib7","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/uog.26233","article-title":"Performance of first-trimester combined screening for preterm pre-eclampsia: findings from cohort of 10 110 pregnancies in Spain","volume":"62","author":"Cuenca-G\u00f3mez","year":"2023","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.032_bib8","doi-asserted-by":"crossref","first-page":"199.e1","DOI":"10.1016\/j.ajog.2018.11.1087","article-title":"Predictive performance of the competing risk model in screening for preeclampsia","volume":"220","author":"Wright","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.032_bib9","doi-asserted-by":"crossref","first-page":"650.e1","DOI":"10.1016\/j.ajog.2019.09.041","article-title":"Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population","volume":"221","author":"Chaemsaithong","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.032_bib10","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/CIRCULATIONAHA.124.069907","article-title":"Implementation of first-trimester screening and prevention of preeclampsia: a stepped wedge cluster-randomized trial in Asia","volume":"150","author":"Nguyen-Hoang","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2025.10.032_bib11","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1161\/HYPERTENSIONAHA.123.22584","article-title":"Prospective validation of first-trimester screening for preterm preeclampsia in nulliparous women (PREDICTION study)","volume":"81","author":"Guerby","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2025.10.032_bib12","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/uog.17455","article-title":"Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11\u201313 weeks\u2019 gestation: comparison with NICE guidelines and ACOG recommendations","volume":"49","author":"O\u2019Gorman","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.032_bib13","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1055\/s-0044-1782676","article-title":"Comparison of national factor-based models for preeclampsia screening","volume":"41","author":"Ghesqui\u00e8re","year":"2024","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2025.10.032_bib14","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.032_bib15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000336662","article-title":"Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis","volume":"31","author":"Roberge","year":"2012","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajog.2025.10.032_bib16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/uog.12421","article-title":"Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis","volume":"41","author":"Roberge","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.032_bib17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajog.2017.11.561","article-title":"Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis","volume":"218","author":"Roberge","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.032_bib18","first-page":"551","article-title":"Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis","volume":"29","author":"Roberge","year":"2012","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2025.10.032_bib19","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.ajog.2025.04.046","article-title":"Aspirin delays preeclampsia in women with chronic hypertension","volume":"233","author":"Bujold","year":"2025","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.032_bib20","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus Placebo in Pregnancies at High Risk for preterm Preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2025.10.032_bib21","doi-asserted-by":"crossref","first-page":"685.e1","DOI":"10.1016\/j.ajog.2017.08.110","article-title":"Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia","volume":"217","author":"Wright","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.032_bib22","series-title":"Hypertension in pregnancy: diagnosis and management","year":"2023"},{"issue":"Suppl1","key":"10.1016\/j.ajog.2025.10.032_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention","volume":"145","author":"Poon","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2025.10.032_bib24","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jogc.2022.03.002","article-title":"Guideline no. 426: hypertensive disorders of pregnancy: diagnosis, prediction, prevention, and management","volume":"44","author":"Magee","year":"2022","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ajog.2025.10.032_bib25","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"ACOG practice bulletin, number 222","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.032_bib26","doi-asserted-by":"crossref","first-page":"580.e1","DOI":"10.1016\/j.ajog.2019.02.034","article-title":"Aspirin delays the development of preeclampsia","volume":"220","author":"Wright","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.032_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2023.101000","article-title":"Comparing Aspirin 75 to 81 mg vs 150 to 162 mg for prevention of preterm preeclampsia: systematic review and meta-analysis","volume":"5","author":"Ghesquiere","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.ajog.2025.10.032_bib28","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/uog.23668","article-title":"ASPRE trial: risk factors for development of preterm pre-eclampsia despite aspirin prophylaxis","volume":"58","author":"Shen","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.032_bib29","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/j.ajog.2025.01.022","article-title":"Prevention of preeclampsia with aspirin: studies are needed to more fully understand the populations most likely to benefit from it","volume":"232","author":"Jiang","year":"2025","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.032_bib30","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1016\/j.ajog.2025.04.042","article-title":"The risk for preeclampsia at 36 weeks and at 12 weeks predicts intrapartum fetal compromise and spontaneous onset of labor","volume":"233","author":"Cavoretto","year":"2025","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.032_bib31","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/HYPERTENSIONAHA.122.20565","article-title":"Preeclampsia prevention by timed birth at term","volume":"80","author":"Magee","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2025.10.032_bib32","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ajog.2023.06.031","article-title":"Optimal dose of aspirin for the prevention of preterm preeclampsia","volume":"229","author":"Ghesquiere","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.032_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2024.12.009","article-title":"Enhancing preeclampsia prevention: insights from aspirin dosage studies","volume":"232","author":"Dong","year":"2025","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.032_bib34","doi-asserted-by":"crossref","first-page":"474.e1","DOI":"10.1016\/j.ajog.2024.10.023","volume":"232","author":"Vinogradov","year":"2025","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.032_bib35","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ajog.2023.06.032","article-title":"Randomized controlled trials to assess optimal aspirin dose are warranted","volume":"229","author":"Horgan","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.032_bib36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ajog.2022.11.1302","article-title":"Association of checklist usage with adherence to recommended prophylactic low-dose aspirin for prevention of preeclampsia","volume":"228","author":"Zhou","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.032_bib37","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ajog.2022.09.046","article-title":"Low-dose aspirin for the prevention of superimposed preeclampsia in women with chronic hypertension: a systematic review and meta-analysis","volume":"228","author":"Richards","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.032_bib38","doi-asserted-by":"crossref","first-page":"342.e1","DOI":"10.1016\/j.ajog.2023.12.031","article-title":"Aspirin for evidence-based preeclampsia prevention trial: effects of aspirin on maternal serum pregnancy-associated plasma protein A and placental growth factor trajectories in pregnancy","volume":"231","author":"Rolnik","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.032_bib39","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2023.04.039","article-title":"Society for Maternal-Fetal Medicine Special Statement: prophylactic low-dose aspirin for preeclampsia prevention-quality metric and opportunities for quality improvement","volume":"229","author":"Society for Maternal-Fetal Medicine (SMFM)","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.032_bib40","doi-asserted-by":"crossref","first-page":"392.e1","DOI":"10.1016\/j.ajog.2024.08.025","article-title":"Soluble fms-like tyrosine kinase-1\/placental growth factor ratio at 36 weeks\u2019 gestation: association with spontaneous onset of labor and intrapartum fetal compromise in low-risk pregnancies","volume":"232","author":"Farina","year":"2025","journal-title":"Am J Obstet Gynecol"},{"issue":"57","key":"10.1016\/j.ajog.2025.10.032_bib41","first-page":"e1","article-title":"The 36-week preeclampsia risk by the Fetal Medicine Foundation algorithm is associated with fetal compromise following induction of labor","volume":"233","author":"Farina","year":"2025","journal-title":"Am J Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937825008087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937825008087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T11:53:31Z","timestamp":1781006011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937825008087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0002937825008087"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2025.10.032","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of aspirin on the risk of preeclampsia based on the Fetal Medicine Foundation first-trimester risk","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2025.10.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}